WHO ICTRP trial
The effect of sildenafil in improving ovarian torsion
IRCT20191104045328N36 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20191104045328N36 |
|---|---|
| Public title | The effect of sildenafil in improving ovarian torsion |
| Scientific title | Investigating the effect of sildenafil on vascular reperfusion after ovarian torsion in women with ovarian torsion |
| Primary sponsor | Arak University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Ovarian torsion. Torsion of ovary, ovarian pedicle and fallopian tube;N83.5 |
| Interventions | Intervention 1: Intervention group: After surgery, sildenafil is given to the patient vaginally at a dose of 25 mg every 8 hours for three days. Intervention 2: Control group: After surgery, the patient will not be given any medication… |
| Registration date | May 6, 2025 |
| Target size | 22 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: